Publicaciones en colaboración con investigadores/as de University of Tennessee Health Science Center (13)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

  3. Event-free survival of maralixibat-treated patients with Alagille syndrome compared to a real-world cohort from GALA

    Hepatology (Baltimore, Md.), Vol. 79, Núm. 6, pp. 1279-1292

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. Posttransplant Management of Recipients Undergoing Liver Transplantation for Hepatocellular Carcinoma. Working Group Report From the ILTS Transplant Oncology Consensus Conference

    Transplantation, Vol. 104, Núm. 6, pp. 1143-1149

2017

  1. S100P as a Marker for Urothelial Histogenesis: A Critical Review and Comparison with Novel and Traditional Urothelial Immunohistochemical Markers

    Advances in Anatomic Pathology, Vol. 24, Núm. 3, pp. 151-160

2016

  1. Targeting the cardiac myofibroblast secretome to treat myocardial fibrosis in heart failure

    Circulation: Heart Failure, Vol. 9, Núm. 8

2015

  1. Building a National Pediatric Cancer Center and Network in Paraguay: Lessons for Addressing Challenges in a Low-income Country

    Journal of Pediatric Hematology/Oncology, Vol. 37, Núm. 5, pp. 383-390

  2. Differential organization of cortical inputs to striatal projection neurons of the matrix compartment in rats

    Frontiers in Systems Neuroscience, Vol. 9, Núm. APR

2013

  1. Management of children with brain tumors in paraguay

    Neuro-Oncology, Vol. 15, Núm. 2, pp. 235-241

2011

  1. Height at diagnosis and birth-weight as risk factors for osteosarcoma

    Cancer Causes and Control, Vol. 22, Núm. 6, pp. 899-908

2008

  1. Fibrosis. A Living Tissue and the Infarcted Heart

    Journal of the American College of Cardiology

2003

  1. Minimal residual disease monitoring by flow cytometry

    Best Practice and Research: Clinical Haematology, Vol. 16, Núm. 4, pp. 599-612